The FDA approved Merck & Co Inc’s (NYSE:MRK) Keytruda (pembrolizumab) in combination with Astellas Pharma Inc (OTC:ALMPF) & Seagen Inc’s (NASDAQ:SGEN) Padcev (enfortumab vedotin-ejfv) locally…

ALMPF

US Stock Futures Signal Lower Start On Wall Street; Verizon, American Express Earnings In Focus

By Lisa Levin

October 21, 5:31 AM

Pre-open movers U.S. stock futures traded lower in early pre-market trade on Friday after closing lower in the previous session. The Dow Jones dropped by 90 points on Thursday. US initial jobless claims declined by 12,000 to 214,000 in the week ending October 15th, compared to market estimates of 230,000.

AXP

Transphorm Enters Into Agreements To Raise $9.3M From The Exercise Of Existing Warrants And A Private Placement Of Common Stock

By Happy Mohamed

April 3, 9:19 AM

Transphorm, Inc. (NASDAQ:TGAN) ("Transphorm" or the "Company"), a pioneer in and global supplier of high-reliability, high-performance gallium nitride (GaN) power conversion products, announced today

TGAN

Guggenheim Initiates Coverage On Fortinet with Neutral Rating

Related Posts

Credit Suisse Upgrades Boeing to Neutral, Announces $200 Price Target

FDA Approves Merck’s Keytruda Combined With Seagen/Astellas’s Padcev For Advanced Urothelial Cancer

US Stock Futures Signal Lower Start On Wall Street; Verizon, American Express Earnings In Focus

Transphorm Enters Into Agreements To Raise $9.3M From The Exercise Of Existing Warrants And A Private Placement Of Common Stock